A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...

Sleep apnea affects millions of people worldwide and prevents them from getting quality sleep. It negatively affects patients ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

Obstructive sleep apnea is a condition that disrupts rest, leading to symptoms such as daytime fatigue, brain fog and ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...

The government-funded insurance plan will now pay for the drug for patients with obstructive sleep apnea, a condition that ...

Decreased blood flow of the optic nerve head (MA, MV, and MT measurements) was significantly correlated with increased OSA ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

Both Novo Nordisk and Eli Lilly are studying their weight loss drugs to treat fatty liver disease, chronic kidney disease, ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...